BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27240017)

  • 21. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
    Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
    Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
    Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
    Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
    Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
    Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients.
    Kotur-Stevuljevic J; Bogavac-Stanojevic N; Jelic-Ivanovic Z; Stefanovic A; Gojkovic T; Joksic J; Sopic M; Gulan B; Janac J; Milosevic S
    Atherosclerosis; 2015 Jul; 241(1):192-8. PubMed ID: 26016451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
    Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
    Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase 1 activity and level of antibodies directed against oxidized low density lipoproteins in a group of an elderly population in Poland - PolSenior study.
    Bednarska-Makaruk M; Rodo M; Szirkowiec W; Mossakowska M; Puzianowska-Kuźnicka M; Skalska A; Zdrojewski T; Ryglewicz D; Wehr H
    Arch Gerontol Geriatr; 2015; 60(1):153-61. PubMed ID: 25459919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.
    Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J
    Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of paraoxonase 1 and lipid profile in healthy children.
    Sumegová K; Nagyová Z; Waczulíková I; Zitnanová I; Duracková Z
    Physiol Res; 2007; 56(3):351-357. PubMed ID: 16792468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The age-related paraoxonase 1 response is altered by long-term caloric restriction in male and female rats.
    Thomàs-Moyà E; Gianotti M; Proenza AM; Lladó I
    J Lipid Res; 2006 Sep; 47(9):2042-8. PubMed ID: 16816326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
    Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
    J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance.
    Agirbasli M; Tanrikulu A; Erkus E; Azizy M; Sevim BA; Kaya Z; Taskin A; Aksoy N; Demirbag R
    Acta Cardiol; 2014 Dec; 69(6):679-85. PubMed ID: 25643439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small Dense Low Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women: Quality or Quantity?
    Mogarekar MR; Kulkarni SK
    Arch Med Res; 2015 Oct; 46(7):534-8. PubMed ID: 26348135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraoxonase-1 is a better indicator than HDL of Atherosclerosis - A pilot study in North Indian population.
    Singh K; Singh R; Chandra S; Tyagi S
    Diabetes Metab Syndr; 2018 May; 12(3):275-278. PubMed ID: 29254890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
    Soran H; Schofield JD; Liu Y; Durrington PN
    Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum paraoxonase 1 status and its association with atherogenic indexes in gentamicin-induced nephrotoxicity in rats treated with coenzyme Q10.
    Ahmadvand H; Ghasemi Dehnoo M; Dehghani A; Bagheri S; Cheraghi RA
    Ren Fail; 2014 Apr; 36(3):413-8. PubMed ID: 24320085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
    Bayram F; Kocer D; Ozsan M; Muhtaroglu S
    Gynecol Endocrinol; 2012 Jul; 28(7):497-501. PubMed ID: 22703625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.